Trial To Assess Chelation Therapy (TACT)

I think that those of us should be mad as he** because of the silence on any results of this test. It was started in 2002, but recruitment started in 2003. Still here we are, suffering and dying from CAD and I have not heard anything about any results. Have any of you? Our tax money is paying for this trial.

I must admit that I have not tried to contact these people at OSU. I have tried to contact a few, different trial contact personnel before, but could never reach anyone.

We CAD folks need to demand information. There is an association of regular mds that are using this chelation (pronounced keelation), setting standards, teaching other mds how to perform the therapy. I have forgot the name or acronym of this medical association. I think alternative doctors and maybe naturopathic practitioners may be receiving this training to perform the chelation therapy. This aspect does not matter to me. I just want to know if it works.

You can get it now, but I do not know if it is FDA approved. I do know that insurance does not pay for it, and it is very expensive. It also depletes some vitamins/minerals from the body that must be replenished.

I went to a naturopath about 2.5 years ago, not for heart disease but for FM and CFS, and he wanted me to start this chelation therapy. It would have cost me around $5-$6k /year and require about 36, 3 or 4 hour sessions per year. He didn't mention this treatment cleaning out arteries. It just cured all ailments...

--------------------------------------------------------------------------------------------------------------------------------------
Research Topic: Alternative/Complimentary Treatment for Coronary Heart Disease (CHD)


Trial Name: Trial To Assess Chelation Therapy (TACT)

Trial Description: TACT is a randomized, double-blind, placebo-controlled trial testing the effectiveness of chelation therapy in reducing the incidence of cardiovascular events (myocardial infarction, stroke) in people diagnosed with coronary heart disease (CHD). Specifically, chelation therapy is an alternative/complimentary medicine treatment that involves the intravenous administration of the drug EDTA (disodium ethylenediaminetetraacetic acid) combined with high-dose antioxidant vitamin and mineral supplements.

Participants are randomized to receive either the standard chelation therapy solution as recommended by the American College for Advancement in Medicine or a placebo solution. All participants are followed for an average of 2.5 years.

Trial Eligibility:

Women (post-menopausal only) and men at least 50 years of age
Prior history of myocardial infarction (MI), with at least one of the following:
-Ischemic symptoms
-Pathological Q waves
-ST-segment changes
-Imaging evidence of myocardial scar
-Current non-smoker for at least 3 months

Trial Sponsor: (OSU Principal Investigator)

National Center of Complementary Medicine; National Heart, Lung, and Blood Institute; and National Institutes of Health (Raymond Magorien, MD)

Contact For Additional Trial Information:

Trial Coordinator: Ovidiu Adam, MD, MS
Phone: [phone]; Pager: 346-0330
E-mail: Ovidiu.***@****

OSUIRB Approval 10/18/04

http://medicalcenter.osu.edu/patientcare/healthcare_services/heart/heart_research/atherosclerosis/